Sandler SG. Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous Rho (D) immune globulin. Transfus Med Rev 2001;15:67-76.10.1053/tmrv.2001.19953Search in Google Scholar
Rushin J, Rumsey DH, Ewing CA, et al. Detection of multiple passively acquired alloantibodies following infusions of intravenous Rh immune globulin. Transfusion 2000;40:551-4.10.1046/j.1537-2995.2000.40050551.xSearch in Google Scholar
McMillian R, Lopez-Dee J, Loftus JC. Autoantibodies to αIIbβ3 in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on αIib. Blood 2001;97:2171-2.10.1182/blood.V97.7.2171Search in Google Scholar
Dixon R, Rosse W, Ebbert L. Quantitative determination of antibody in idiopathic thrombocytopenic purpura. Correlation of serum and platelet-bound antibody with clinical response. N Engl J Med 1975;292:230-6.10.1056/NEJM197501302920503Search in Google Scholar
Karpatkin S, Strick N, Karpatkin MB, et al. Cumulative experience in the detection of antiplatelet antibody in 234 patients with idiopathic thrombocytopenic purpura, systemic lupus erythematosus and other clinical disorders. Am J Med 1972;52:776-85.10.1016/0002-9343(72)90084-8Search in Google Scholar
Hou M, Stockelberg D, Kutti J. Immunoglobulins targeting both GPIIb/IIIa and GPIb/IX in chronic idiopathic thrombocytopenic purpura (ITP): evidence for at least two different IgG antibodies. Br J Haematol 1997;98:64-7.10.1046/j.1365-2141.1997.1883006.xSearch in Google Scholar
Williams Y, Lynch S, McCann S, et al. Correlation of platelet Fc gammaRIIA polymorphism in refractory idiopathic (immune) thrombocytopenic purpura. Br J Haematol 1998;101:779-82.10.1046/j.1365-2141.1998.00802.xSearch in Google Scholar
Hurlimann-Forster M, Steiner B, von Felten A. Quantitation of platelet-specific autoantibodies in platelet eluates of ITP patients measured by a novel ELISA using the purified glycoprotein complexes GPIIb/IIIa and GPIb/IX as antigens. Br J Haematol 1997;98:328-35.10.1046/j.1365-2141.1997.2423059.xSearch in Google Scholar
Bussel JB. Fc receptor blockade and immune thrombocytopenic purpura. Semin Hematol 2000;37:261-6.10.1016/S0037-1963(00)90104-5Search in Google Scholar
Kaznelson P. Verschwinden den haemorrhagischen diathese bei einem fallen von essentieller thrombopenia (Frank) nach milz extripation. Splenogene thrombolitsche purpura. Wien Klin Wochenschr 1916;29:1451-4.Search in Google Scholar
Wintrobe MM. ACTH and cortisone in hemopoietic disorders. Am J Med 1950;9:715-7.10.1016/0002-9343(50)90285-3Search in Google Scholar
Imbach P, Barandum S, D’Appuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in children. Lancet 1981;1:1228-30.10.1016/S0140-6736(81)92400-4Search in Google Scholar
Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia: competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells? Lancet 1983;2:193-5.10.1016/S0140-6736(83)90175-7Search in Google Scholar
Salama A, Kiefel V, Amberg R, et al. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rho[D]). Blut 1984;49:29-35.10.1007/BF00320381Search in Google Scholar
Salama A, Kiefel V, Mueller-Eckhardt C. Effect of IgG anti-Rho(D) in adult patients with chronic autoimmune thrombocytopenia. Am J Hematol 1986;22:241-51.10.1002/ajh.2830220304Search in Google Scholar
Becker T, Kuenzlen E, Salama A, et al. Treatment of childhood idiopathic thrombocytopenic purpura with rhesus antibodies (anti-D). Eur J Pediatr 1986; 145:166-99.10.1007/BF00446055Search in Google Scholar
Oksenhendler E, Bierling P, Bossard Y, et al. Anti-Rh immunoglobulin therapy for human immunodeficiency virus related immune thrombocytopenic purpura. Blood 1988;71:1499-502.10.1182/blood.V71.5.1499.1499Search in Google Scholar
Bussel JB, Graziano JN, Kimberly RP, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity and mechanism of effect. Blood 1991;77:1884-94.10.1182/blood.V77.9.1884.1884Search in Google Scholar
Gringeri A, Cattaneo M, Santagostino E, et al. Intramuscular anti-D immunoglobulins for home treatment of chronic immune thrombocytopenic purpura. Br J Haematol 1992;80:337-40.10.1111/j.1365-2141.1992.tb08142.xSearch in Google Scholar
Andrew M, Blanchette VS, Adams M, et al. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D. J Pediatr 1992;120:552-7.10.1016/S0022-3476(10)80001-0Search in Google Scholar
Caglayan S, Aksit S, Yaprak I, et al. Steroid-free interval with anti-D in chronic idiopathic thrombocytopenic purpura. Acta Paediatr Jpn 1993;35:36-8.10.1111/j.1442-200X.1993.tb03002.xSearch in Google Scholar
Borgna-Pignatti C, Battisti L, Zecca M, et al. Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins. Br J Haematol 1994;88:618-20.10.1111/j.1365-2141.1994.tb05083.xSearch in Google Scholar
Blanchette V, Imbach P, Andrew M, et al. Randomized trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703-7.10.1016/S0140-6736(94)92205-5Search in Google Scholar
Godeau B, Oksenhendler E, Bartholeyns J, et al. Treatment of chronic autoimmune thrombocytopenic purpura with monoclonal anti-D. Transfusion 1996;36:328-30.10.1046/j.1537-2995.1996.36496226146.x8623133Search in Google Scholar
Scaradavou A, Woo B, Woloski BMR, et al. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 1997;89:2689-700.10.1182/blood.V89.8.2689Search in Google Scholar
Newman GC, Novoa MV, Fodero EM, Lesser ML, Woloski BM, Bussel JB. A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/ kg/d in adults with immune thrombocytopenic purpura. Br J Haematol 2001;112:1076-8.10.1046/j.1365-2141.2001.02627.x11298610Search in Google Scholar
Bussel JB, Kaufmann CP, Ware RE, Woloski BM. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy? Am J Hematol 2001; 67:27-33.10.1002/ajh.107211279654Search in Google Scholar
Shulman NR, Weinrach RS, Libre EP, Andrews HL. The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura. Trans Assoc Am Physicians 1965;78:374-90.Search in Google Scholar
Rho(D) Immune Globulin Intravenous (Human)/ WinRho SDF™ package insert. January 20, 2000. Winnepeg, Canada: Cangene Corporation. Distributed by NABI, Boca Raton, FL.Search in Google Scholar
Kennedy MS, McNanie J, Waheed A. Detection of anti-D following antepartum injections of Rh immune globulin. Immunohematology 1998;14:138-40.10.21307/immunohematology-2019-681Search in Google Scholar
Roberti I, Bagtas JF, Reisman L, Murphy S. Severe acute renal failure due to hemoglobinuria after use of WinRho for the treatment of idiopathic thrombocytopenic purpura. Clin Pediatr 2001;40:61-2.10.1177/00099228010400011411210091Search in Google Scholar
